| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/10/2013 | CA2849866A1 In vivo adcc model |
| 05/10/2013 | CA2849210A1 Antibody formulations |
| 05/09/2013 | US20130117871 Human Antibodies Derived from Immunized Xenomice |
| 05/09/2013 | US20130115675 Dehalogenases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 05/09/2013 | US20130115674 Human Monoclonal Antibodies to Human Nucleolin |
| 05/09/2013 | US20130115657 Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 05/09/2013 | US20130115626 Anti-neuropilin antibodies and methods of use |
| 05/09/2013 | US20130115625 Novel protein and use thereof |
| 05/09/2013 | US20130115603 Nucleotide repeat expansion-associated polypeptides and uses thereof |
| 05/09/2013 | US20130115230 Delivery proteins |
| 05/09/2013 | US20130115229 Method for detecting malignant tumor cells |
| 05/09/2013 | US20130115227 Anti-addl monoclonal antibody and uses thereof |
| 05/09/2013 | US20130115225 Reducer of immunosuppression by tumor cell and antitumor agent using the same |
| 05/09/2013 | US20130115224 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/09/2013 | US20130115223 Antagonists of pcsk9 |
| 05/09/2013 | US20130115218 Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides |
| 05/09/2013 | US20130115217 Antibodies against hmgb1 and fragments thereof |
| 05/09/2013 | US20130115216 Survivin-derived peptides and uses thereof |
| 05/09/2013 | US20130115215 Domain insertion immunoglobulin |
| 05/09/2013 | US20130115214 Neuropilin antagonists |
| 05/09/2013 | US20130115213 Human cd3-specific antibody with immunosuppressive properties |
| 05/09/2013 | US20130115211 Cytokine antagonists for neurological and neuropsychiatric disorders |
| 05/09/2013 | US20130115209 Protective vaccine based on staphylococcus aureus protein sa2412 |
| 05/09/2013 | US20130115208 Heterodimeric proteins and methods for producing and purifying them |
| 05/09/2013 | US20130115206 Compositions and Methods for Treating and Diagnosing Cancer |
| 05/09/2013 | US20130115191 T cell receptor fusions and conjugates and methods of use thereof |
| 05/09/2013 | US20130115166 Anti-il-23 heterodimer specific antibodies |
| 05/08/2013 | EP2589654A1 CD40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity |
| 05/08/2013 | EP2589610A1 Human c-fms antigen binding proteins |
| 05/08/2013 | EP2589609A1 Antigen binding protein and its use as addressing product for the treatment of cancer |
| 05/08/2013 | EP2588866A1 Diagnosis and treatment of brain tumors |
| 05/08/2013 | EP2588631A2 Protein kinase ck2 gene mutations, amplifications and polymorphisms in human cancers and methods of use |
| 05/08/2013 | EP2588499A1 Antibodies that are capable of specifically binding tissue factor pathway inhibitor |
| 05/08/2013 | EP2588498A1 Llt-1 antibodies with new functional properties |
| 05/08/2013 | EP2588497A1 Novel antibody for the diagnosis and/or prognosis of cancer |
| 05/08/2013 | EP2588496A1 REAGENTS AND METHODS FOR DIAGNOSING CONDITIONS ASSOCIATED WITH HYDROXYLATED HIF 1-alpha |
| 05/08/2013 | EP2588495A1 Histone citrullinated peptides and uses thereof |
| 05/08/2013 | EP2588211A2 Env trimer immunogens |
| 05/08/2013 | EP2588142A2 Factor viia complex using an immunoglobulin fragment |
| 05/08/2013 | EP2588138A1 Treatment of vascularized pigment epithelial detachment with anti-vegf therapy |
| 05/08/2013 | EP2588120A2 Compositions and methods related to protein a (spa) variants |
| 05/08/2013 | EP2588115A1 Aptamers that inhibit interaction between antibody and 2nd extracellular loop of human beta-1-adrenergic receptor |
| 05/08/2013 | DE112011102397T5 Pharmazeutische Kombinationszusammensetzungen und Verfahren zur Behandlung von Schwindel, Kinetose und vegetativ-vaskulärer Dystonie A pharmaceutical combination compositions and methods for treating vertigo, motion sickness and vegetative-vascular dystonia |
| 05/08/2013 | CN1798768B Anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
| 05/08/2013 | CN103097524A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases |
| 05/08/2013 | CN103097523A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl tRNA synthetases |
| 05/08/2013 | CN103097418A Anti-neuropilin antibodies and methods of us |
| 05/08/2013 | CN103097417A Heterodimeric antibody FC-containing proteins and methods for production thereof |
| 05/08/2013 | CN103097416A Humanized IL-25 antibodies |
| 05/08/2013 | CN103097415A Humanised antigen binding proteins to myostatin6 |
| 05/08/2013 | CN103097414A Annexin 1 antibody |
| 05/08/2013 | CN103097413A Lipid-conjugated antibodies |
| 05/08/2013 | CN103097412A Anti-human respiratory syncytial virus (RSV) antibodies and methods of use |
| 05/08/2013 | CN103097411A Carbohydrate binding module and use thereof |
| 05/08/2013 | CN103097410A Improved antibodies of the class IgG4 |
| 05/08/2013 | CN103097399A Compositions and methods for the removal of biofilms |
| 05/08/2013 | CN103096933A Multifunctional antibody conjugates |
| 05/08/2013 | CN103096927A Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract |
| 05/08/2013 | CN103096926A Combination therapy of an afucosylated CD20 antibody with an anti- VEGF antibody |
| 05/08/2013 | CN103091492A Diagnostic reagent and kit for cancer |
| 05/08/2013 | CN103088033A Antibody gene for resisting pyrethriods pesticide scFv (Single Chain Fragment Variable) and application of antibody gene |
| 05/08/2013 | CN103087994A Coxsackievirus A16-type virus strain and use thereof |
| 05/08/2013 | CN103087196A Preparation method of muramyl dipeptide-anti-CD20 immune conjugate and application thereof |
| 05/08/2013 | CN103087195A Dual-specificity monoclonal antibody for resisting chloramphenicol and apramycin and preparation method thereof |
| 05/08/2013 | CN103087194A Anti-blood-cycle-venin egg yolk antibody and application thereof |
| 05/08/2013 | CN103087193A Method for preparing human neuron specific enolase (NSE) monoclonal antibody through gene immunization |
| 05/08/2013 | CN103087192A Anti-KDR antibodies and methods of use |
| 05/08/2013 | CN103087191A Monoclonal antibody of anti-human NT-proBNP polypeptide and application thereof |
| 05/08/2013 | CN103087190A Anti-gm-csf antibodies and uses therefor |
| 05/08/2013 | CN103087189A Method for obtaining polyclonal antibody of sheep independent growth factor 1B |
| 05/08/2013 | CN103087188A Immunoglobulin fraction and process therefor |
| 05/08/2013 | CN103087173A Synthetic peptide vaccine of B cell epitope based on TGF(transforming growth factor)-beta1 and application thereof |
| 05/08/2013 | CN103087154A Polypeptide for preparing monoclonal antibody for detecting acetylcholin esterase and application of polypeptide |
| 05/08/2013 | CN103083665A Destruction of tumor cells by trifunctional bispecific antibodies with low to medium expression levels of tumor-associated target antigens |
| 05/08/2013 | CN102286101B Fab (fragment of antigen binding) fragment Vasculizumab of anti-VEGF (vascular endothelial growth factor) monoclonal antibody and application thereof |
| 05/08/2013 | CN102276722B Novel vascular endothelial growth factor humanized monoclonal antibody |
| 05/08/2013 | CN102241770B Influenza virus M2-targeted ion channel protein VHH (Vibrio Harveyi Haemolysin) gene engineering antibody and coding gene and application thereof in preparation of anti-influenza-virus drug |
| 05/08/2013 | CN102212131B Binding molecules capable of neutralizing rabies virus and uses thereof |
| 05/08/2013 | CN102127523B Hybridoma cell line and application thereof |
| 05/08/2013 | CN102120772B Chimeric antibody and immunocyte |
| 05/08/2013 | CN102060925B Interleukin-13 antibody composition |
| 05/08/2013 | CN101988925B ELISA (Enzyme Linked Immunosorbent Assay) reagent kit for detecting Hum j3 specific IgE antibodies |
| 05/08/2013 | CN101921337B Antibody against lactate dehydrogenase of plasmodium vivax, related preparation method, hybridoma cell strain and application |
| 05/08/2013 | CN101907623B Method for detecting gentamicin and/or micronomicin and special quantum dot fluorescence immunoassay kit thereof |
| 05/08/2013 | CN101863980B Whole human source anti-vascular endothelial cell growth factor receptor 2 single chain antibody |
| 05/08/2013 | CN101400703B Domain antibody construct |
| 05/07/2013 | US8436151 Indoleamine 2,3-dioxygenase-2 antibodies |
| 05/07/2013 | US8436150 Humanized C-kit antibody |
| 05/07/2013 | US8436149 Crystalline anti-hTNFalpha antibodies |
| 05/07/2013 | US8436148 Antibodies against interleukin-18 binding protein, their preparation and use |
| 05/07/2013 | US8436146 Therapeutic use of anti-CS1 antibodies |
| 05/07/2013 | US8436145 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to Beclin-1 |
| 05/07/2013 | US8436143 T1R taste receptors and genes encoding same |
| 05/07/2013 | US8436139 Apo-lipoprotein B fragment for use in prevention and treatment of cardiovascular and ischemic disorders |
| 05/07/2013 | US8436137 Selective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide |
| 05/07/2013 | US8436136 Peptide complex |
| 05/07/2013 | US8435801 Methods and compositions for the production of monoclonal antibodies |
| 05/07/2013 | US8435754 Method of diagnosing the presence of a tumor in a mammal by assessing CDO expression levels |
| 05/07/2013 | US8435749 Anti-CDH3 antibodies labeled with radioisotope label and uses thereof |
| 05/07/2013 | US8435733 Screening methods for transfusion related acute lung injury |